TXG · Categories · M&A
TXG - Mergers and acquisitions
10x Genomics Inc. (TXG) mergers and acquisitions - real-time wire coverage filtered to M&A only.
Recent M&A for TXG
- 10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech GroupAcquisition Expands 10x Genomics' Capabilities in Proteomics PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- 10x Genomics, Inc. (NASDAQ:TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the acquisition of Proteintech Genomics, a division within Proteintech Group, a company specializing in developing high-plex proteomic solutions for single cell and spatial applications on 10x platforms. The acquisition marks a strategic expansion of 10x's proteomics capabilities. Proteintech Genomics brings differentiated technologies, including its Human Discovery Panel, the l
- 10x Genomics Reports First Quarter 2021 Financial ResultsPLEASANTON, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (NASDAQ:TXG) today reported financial results for the first quarter ended March 31, 2021. Recent Highlights Revenue was $105.8 million for the first quarter, representing a 47% increase over the corresponding period of 2020Launched Single Cell Gene Expression with CellPlex and Chromium Single Cell Gene Expression Low Throughput Kits to increase access to and affordability of single cell analysis and enable single cell for allShowcased new products and capabilities across three product platforms, Chromium Single Cell, Visium Spatial and In Situ Analysis, and announced the acquisition of Tetramer Shop at the first
- 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience EventPLEASANTON, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10x’s three product platforms: Chromium Single Cell, Visium Spatial, and In Situ Analysis. Tetramer Shop marks the fifth acquisition for 10x Genomics in its ongoing mission to master biology to advance human health. This acquisition follows the additions of epigenomics innovator Epinomics and spatial genomics pioneer Spatial Transcriptomics in 2018, as well as In Situ analysis companies CartaNA AB and ReadCo